Mixed-methods study on pharmacies as contraception providers to Kenyan young people : who uses them and why? by Gonsalves, Lianne et al.
1Gonsalves L, et al. BMJ Open 2020;10:e034769. doi:10.1136/bmjopen-2019-034769
Open access 
Mixed- methods study on pharmacies as 
contraception providers to Kenyan 
young people: who uses them and why?
Lianne Gonsalves   ,1,2,3 Kaspar Wyss,2,3 Jenny A Cresswell   ,1 
Michael Waithaka   ,4 Peter Gichangi   ,4,5,6 Adriane Martin Hilber2,3
To cite: Gonsalves L, Wyss K, 
Cresswell JA, et al.  Mixed- 
methods study on pharmacies 
as contraception providers to 
Kenyan young people: who 
uses them and why? BMJ Open 
2020;10:e034769. doi:10.1136/
bmjopen-2019-034769
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
034769).
Received 04 October 2019
Revised 10 March 2020
Accepted 18 May 2020
For numbered affiliations see 
end of article.
Correspondence to
Lianne Gonsalves;  
 gonsalvesl@ who. int
Original research
©World Health Organization 
2020. Licensee BMJ.
AbstrACt
Objectives This study sought to answer two questions: (1) 
what are the characteristics of young Kenyans aged 18–24 
who use contraception obtained at pharmacies, and (2) 
why are pharmacies appealing sources of contraception?
Design and setting This was a mixed- methods study 
in one peri- urban part of Kwale County, Kenya. Methods 
included cross- sectional survey (n=740), six focus 
group discussions, 18 in- depth interviews and 25 key- 
informant interviews. Quantitative data analysis identified 
factors pushing young people to pharmacies for modern 
contraception versus other sources. Qualitative data 
analysis identified reasons pharmacies were perceived to 
be appealing to young clients.
Participants Participants were (1) young people aged 
18–24 from the study area, including a subset who had 
recently purchased contraception from a pharmacy; or (2) 
pharmacy personnel and pharmacy stakeholders.
results Among surveyed participants who had ever had 
sexual intercourse and had used modern contraception at 
last sexual intercourse, 59% obtained it from a pharmacy. 
In multivariable analysis, participants who used a condom 
or emergency contraception as well as those living 
alone were significantly more likely to get contraception 
from pharmacies. Pharmacies were valued for their 
convenience, privacy, non- judgmental and personable 
staff, service speed, as well as predictable and affordable 
prices.
Conclusions Our findings indicate a high percentage 
of young people in Coastal Kenya use pharmacies for 
contraception. Our inclusion of emergency contraception 
users partially explains this. Pharmacies were perceived 
to be everything that health facilities are not: fast, private 
and non- limiting. Policy- makers should recognise the 
role of pharmacies as contraception providers and look 
for opportunities to link pharmacies to the public health 
system. This would create a network of accessible and 
appealing contraception services for young people.
IntrODuCtIOn
Young people need access to contracep-
tion. However, around the world, and in 
low- income and middle- income countries 
in particular, public sector contraceptive 
services are not meeting this need. Data from 
61 low- income and middle- income countries 
estimated that 33 million young women aged 
15–24 had an unmet need for family plan-
ning.1 Adolescents (ages 10–19 years) and 
youth (15–24 years) are often reluctant to 
access contraception at public health facilities 
where they may encounter a lack of privacy, 
biased providers and limited contraceptive 
options, in addition to broader financial, 
legal, social and cultural barriers.2 3
Other parts of the health system may be able 
to step in to help fill this gap. In Kenya (where 
this study took place) and in the region, 
private pharmacies have become a source of 
modern contraception for young people.4–7 
Additional research has indicated that when 
contraception is introduced in pharmacies, 
access improves for young people.8 9 An anal-
ysis of 33 sub- Saharan African countries found 
that commercial drug sellers, including phar-
macies, were the source of the most recent 
contraceptive method for nearly one in five 
young people between 15 and 24 years of 
age.8 When also factoring in other informal 
and non- medical providers, including shops, 
these sources together serviced nearly half of 
women age 15–19.8
strengths and limitations of this study
 ► Participants were asked to specify where they or 
their partner had obtained the contraception used at 
last sexual intercourse. This is a standard question 
for studies looking to establish contraception prev-
alence. However, our not further ascertaining who 
specifically obtained the contraception affected our 
ability to distinguish differences in preferences of 
young men versus young women.
 ► One participant group (young people who had re-
cently purchased contraception from a pharmacy) 
was recruited from five purposively selected phar-
macies: this may limit the generalisability of the 
findings.
 ► This study is strengthened by its mixed- methods 
design and inclusion of both pharmacy personnel 
and young people to triangulate research findings 
on a sensitive subject.
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Table 1 Study methods
Method N Eligibility criteria Relevant topics addressed
Cross- sectional 
survey*
740  ► Age 18–24  ► Contraception used at last sexual 
intercourse and source
 ► Literate  ► Demographic and behavioural 
characteristics
 ► Have their own mobile phone (with 
them at time of recruitment) and report 
regular use
  
 ► Report current use of text messaging   
Focus group 
discussions*
6  ► Age 18–24  ► Sources of contraception for young 
people
(58 participants)  ► Community members  ► Characteristics of young people who 
use each source
In- depth interviews 18  ► Age 18–24  ► Reasons for having purchased 
contraception from pharmacy
 ► Recently purchased contraception at 
pharmacy








 ► Pharmacy personnel (any role) OR  ► What clients appreciate about 
experience
6 (stakeholders)  ► Pharmacy- related stakeholder 
(Ministry of Health; regulatory agency; 
professional association; non- 
governmental organisation)
  
*Methods which were nested in the broader ARMADILLO study, a digital health intervention randomised controlled trial. Inclusion/exclusion 
criteria for these nested methods were determined by ARMADILLO’s objectives.
Kenya’s National Family Planning Guidelines allow for 
the provision of several kinds of modern methods10 of 
contraception to be dispensed by pharmacists or phar-
maceutical technologists11 (colloquially referred to as 
‘chemists’). These include barrier methods like male 
and female condoms, as well as short- acting methods 
including emergency contraception (ECP), oral contra-
ceptive pills and injectable contraception. These permis-
sions mean that outside of health facilities, private retail 
pharmacies have the largest selection of modern methods 
available (shopkeepers can also sell condoms, per the 
guidelines). Private retail pharmacies must be opened by 
and should always operate under the supervision of either 
a pharmacist or pharmaceutical technologist.12
Despite their demonstrable popularity among young 
people, there are little data on the individual- level circum-
stances or characteristics of young people that would drive 
them to pharmacies for contraception. Therefore, we 
conducted a mixed- methods study describing how young 
people (aged 18–24) in Kwale County obtain contracep-
tion from pharmacies. Kwale County is one of six counties 
in Kenya’s former Coast region. Young people between 
the ages of 15 and 24 were projected to make up 19% 
of the county’s population by 2018.13 In 2014, contracep-
tion prevalence in the county was 38%, lower than the 
national average of 53%.14
In this analysis, we sought to answer two questions: (1) 
what are the characteristics of young people who use 
contraception obtained at pharmacies, and (2) why are 
pharmacies appealing sources of contraception to young 
people?
MethODs
The study took place in the peri- urban areas of Kwale 
Town and Ukunda, as well as the stretch of highway 
connecting the two towns. Data collection took place 
between October 2017 and March 2018. We used several 
methods (captured in table 1) to understand the expe-
riences of pharmacy personnel and young people them-
selves. This study was partly nested in the ARMADILLO 
randomised controlled trial (RCT),15 which assessed 
the effect of an unrelated digital health intervention on 
sexual and reproductive health–related outcomes for 
young people aged 18–24.
To capture the perspectives of young people, a cross- 
sectional survey of young people age 18–24 captured 
demographic information and contraceptive use patterns, 
including source of last contraception (these questions 
were one section of a broader survey conducted as part of 
the baseline assessment for the ARMADILLO trial). The 
sample size was calculated based on the ARMADILLO 
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trial’s primary outcome—the full protocol for the trial 
has been previously published,15 along with details of 
participants recruited.16
To identify participants, we obtained a map of the study 
area from the Kenya National Bureau of Statistics. The 
KNBS divides the country into so- called enumeration 
areas (EAs) in preparation for the country’s 2019 census. 
EAs consist of blocks of households. Each EA had approx-
imately 100 households. In October 2017, data collectors 
enumerated all age- eligible young people in every house-
hold using a random selection of 21 EAs in the study area. 
From this list of age- eligible youth, a random selection of 
households and random selection of one youth per house-
hold was generated. Data collectors visited the selected 
households to recruit participants (who met eligibility 
criteria captured in table 1) starting in February 2018.
In addition, six focus group discussions (FGDs) were 
conducted with young people aged 18–24, purposively 
recruited from the community by data collectors. Finally, 
we conducted in- depth interviews (IDIs) with 18 young 
people aged 18–24 who had recently purchased contra-
ception from pharmacies. We purposively recruited these 
young participants in one of two ways. First, we stationed 
a young data collector outside of well- trafficked pharma-
cies over three evenings, who recruited young people 
purchasing contraception. Second, several pharmacists in 
the study area were provided with leaflets with study infor-
mation and requested to provide these to young contra-
ception purchasers at the end of a transaction.
To capture the perspectives of pharmacy personnel, 
data collectors mapped all private, retail pharmacies in 
the study area using a digital form with an embedded 
geolocator. A random subset of pharmacies was gener-
ated using the random number generator in Excel. Phar-
macies were well distributed across the study area. In 
each selected pharmacy, data collectors were instructed 
to approach the first person behind the counter, regard-
less of rank or level of training, explain the study and 
ask if they would be interested in participating. Nine-
teen interviews in total were conducted. An additional 
six key- informant interviews were conducted with stake-
holders from the regulatory Pharmacy and Poisons 
Board, Ministry of Health, professional associations and 
non- governmental organisations. These were conducted 
in the individuals’ offices in either Ukunda, Mombasa or 
Nairobi. Stakeholder participants were contacted first by 
phone or email, the study explained and a convenient 
time for an in- person visit set.
Data collection and management
We obtained informed consent from all participants 
prior to participation. All data were collected in English, 
Swahili or a mix of the two, depending on participants’ 
preference. Quantitative surveys were close ended and 
administered using webforms on a tablet. Data collec-
tors entered responses save for the questions related 
to participants’ sexual and contraceptive use history; 
here, to reduce potential discomfort and response bias, 
participants entered their own responses. Interviews 
and FGDs used semi- structured guides: FGD (online 
supplementary file S1), IDI (online supplementary file 
S2) and key- informant interview (online supplemen-
tary file S3) guides are provided as online supplemen-
tary material, as are relevant survey components (online 
supplementary file S4). Qualitative data collection was 
informed by ground theory,17 allowing us to adopt an iter-
ative approach, with question guides modified based on 
emerging themes. Qualitative data collection ceased on 
reaching saturation. All qualitative methods used audio- 
recording (with participant permission). All study activi-
ties were conducted in a private location. Data collectors, 
speaking both English and Swahili, were recruited from 
the study area and specifically trained for this study.
Patient and public involvement
Our population (young people) were directly involved 
in parts of the study’s design and implementation. Our 
survey data collection team consisted of young people 
recruited from the study area (Kwale County). Qualitative 
method data collectors were also young people recruited 
from both Kwale and Mombasa Counties. We relied on 
their insight and lived experience to determine how young 
people would feel most comfortable being recruited. We 
jointly designed our recruitment and consenting proce-
dures. A dissemination meeting involving local, county 
and national stakeholders (including some pharmacy 
stakeholder participants) took place in June 2019. Several 
young data collectors were invited to attend and they 
provided commentary on the findings.
researcher characteristics and reflexivity
Data collectors were young people (nearly even numbers 
of men and women—24 in total) recruited from Kwale 
and Mombasa counties. Kwale County data collectors 
were familiar with the study area and recognised within 
their communities, which facilitated enumerating phar-
macies, recruiting youth participants and getting consent 
to interview pharmacy personnel. They were also less 
educated and less experienced than data collectors from 
Mombasa County. This, at times, resulted in a subordi-
nate dynamic with some pharmacy personnel partici-
pants who were university educated. The first author 
conducted all interviews with pharmacy stakeholders. She 
is from the USA (from a racial minority group different 
from the study population) and presented as an outsider 
(someone not from Kenya) to interviewees. Her position 
(leading the study and professional affiliations) resulted 
in respondents treating her collegially and being open to 
participate.
Analysis
Quantitative data were analysed in Stata V.14. The subject 
of the analyses (as described in figure 1) were survey 
participants who reported using one of four contra-
ception commodities available in pharmacies (either 
male or female condom, ECP, daily contraceptive pills 
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Figure 1 Flow diagram of study participants. FGD, focus group discussion; IUD, intrauterine device.
or injectable contraception) at last sexual intercourse 
and who reported their source. Sexual intercourse was 
presumed to be penetrative vaginal sex. Excluded were 
those participants who had not used contraception at 
last sexual intercourse, who had not used a contracep-
tive commodity (withdrawal method, calendar days), 
who could not remember where they had obtained their 
method and/or who had obtained it from a partner or 
friend. We developed a dichotomous ‘source of family 
planning’ outcome, distinguishing between ‘pharmacy’ 
and ‘any other source’. The latter included any public 
or private health facility, community- based distributors, 
non- governmental organisations, shops, schools and 
supermarkets. Following descriptive statistics, bivariate 
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log binomial regressions assessed the association between 
the outcome and each behavioural/sociodemographic 
variable of interest. Any analysis showing a p value <0.2 
moved the variable into a multivariable Poisson regres-
sion model with robust 95% CIs.
All qualitative data were analysed using the Framework 
Method.18 Data were first transcribed verbatim and then 
translated (if necessary) into English. For a subsection of 
Swahili- language interviews, English- language transcripts 
were compared against the original Swahili- language 
interview audio file by another member of the research 
team to ensure consistency. Qualitative analysis for the 
broader study was guided by the five, WHO- defined dimen-
sions of quality health services to adolescents: equity, accessi-
bility, acceptability, appropriateness and effectiveness.19 
All transcripts were read once to improve familiarity with 
the data. Then, qualitative analysis was conducted in 
Atlas. ti V.8, with deductive and then inductive coding of a 
subset of transcripts to develop and refine a coding frame-
work. Deductive coding was informed by the ‘accessibility’ 
and ‘acceptability’ dimensions and broadly captured any 
reference to pharmacies being ‘appealing’. Inductive 
coding of these data then identified specific reasons for 
appeal, subsequently grouping these into broad catego-
ries related to pharmacy outlet, personnel and service 
appeal. These broad categories and individual reasons 
structure the presentation of the qualitative results.
results
survey sample characteristics
A total of 1170 youth were approached for participa-
tion, of which 740 (63%) consented to participate and 
completed the survey. Reasons for non- participation are 
captured in figure 1. As seen in table 2, of the 740 young 
people aged 18–24 who participated in the cross- sectional 
survey, 512 (69%) had ever had sexual intercourse. Male 
condoms were the most popular form of contraception 
purchased, used by 190 of the 274 (69%) participants 
who used contraception at last sexual intercourse. Of the 
participants indicating that they used a modern contra-
ceptive at last sexual intercourse (n=263), 154 (59%, data 
not shown) had obtained it from a private, retail phar-
macy (hereafter, ‘pharmacy’).
Of the 243 participants who were included in bivar-
iate and multivariable analyses, 54% were male, 61% 
had attended secondary school or higher, and 70% were 
dependents (living with parents, grandparents or other 
older family members). A higher proportion of female 
participants than male participants were cohabiting, 
engaged, or married and had at least one child. Male 
participants had attended higher levels of schooling 
than female participants. Online supplementary table 1 
presents selected characteristics of the 243 participants 
disaggregated by whether they obtained contraception at 
a pharmacy, shop or any other source: most shop users 
were male and purchased condoms.
Who accesses contraception from pharmacies?
Bivariate analyses (table 3) indicated there was no 
evidence of an association between either age, sex or 
education and a young person’s contraception being 
from a pharmacy. There was an association between 
pharmacy- purchased contraception and a participant’s 
relationship status, and whether they had children. 
The greatest predictors of whether a young person had 
visited a pharmacy were the type of contraception they 
purchased and with whom they lived. Following multivari-
able analysis (table 3), there remained strong evidence 
of an association between pharmacy purchase of contra-
ception and a young person’s relationship status, living 
situation as well as the type of contraception they used. 
Young people living alone were almost twice as likely to 
have sourced contraception from a pharmacy as those 
living with a child or partner (adjusted prevalence ratio 
(PR) 1.96, 95% CI 1.07 to 3.59). Use of ECP remained the 
greatest predictor of a pharmacy purchase (adjusted PR 
2.27 as compared with pill/injection use, 95% CI 1.21 to 
4.27).
Qualitative methods participant characteristics
Three FGDs were held with young men and three with 
young women—each FGD had approximately 10 partici-
pants. Of the 18 IDI participants, 10 were young women 
and 8 were young men. Female IDI participants had most 
recently purchased emergency contraception (n=7), 
injection (n=2) and condom (n=1). Male IDI participants 
had most recently purchased condom (n=6) and ECP 
(n=2).
Of the 19 key- informant participants, 10 interviewed 
pharmacy personnel were women and 9 were men. Partic-
ipants were not probed in detail on their formal training 
(and therefore whether they should be operating in their 
current role). That said, we could ascertain that 13 of 
the participants had an appropriate amount of training 
for their reported tasks, and 4 did not (the final 2 were 
unclear). Self- reported education ranged from having 
some secondary education to full training as a pharma-
cist or pharmaceutical technologist. One participant was 
a nurse. Stakeholder demographics are not described to 
ensure they remain unidentifiable.
Why are pharmacies appealing?
Participants indicated that it was a combination of the 
pharmacy outlet, the pharmacy personnel themselves and 
the services provided by the pharmacy which together 
made these establishments the preferred source of 
contraception for many young people (table 4).
Pharmacy outlets were appealing because of the conve-
nience and anonymity they offered young clients. Phar-
macies were located where young people lived, worked 
and spent time, making them easy contraception access 
points. If one pharmacy lacked what a young person was 
looking for, it was a short trip to the next one. ‘Conve-
nience’ also extended to the days and hours pharmacies 
were open. This made them especially important on days 
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Table 2 Baseline characteristics
All surveyed participants (n=740)
Female Male Total
Ever had sexual intercourse 231/347 281/393 512/740 (69%)
Used any contraception at last sexual 
intercourse
126/231 (55%) 148/281 (53%) 274/512 (54%)
Used a modern contraceptive at last sexual 
intercourse
118/231 (51%) 145/281 (52%) 263/512 (51%)
Used pharmacy- available contraception* 116/231 (50%) 143/281 (51%) 259/512 (51%)
Where contraception was obtained (n=116) (n=143) (n=259)
  Pharmacy 63% 56% 59%
  Shop 5% 17% 11%
  Public dispensary or health centre 13% 7% 10%
  Hospital 11% 6% 8%
  NGO, private doctor 3% 4% 4%
  Community- based distributor, school, 
supermarket
1% 2% 2%
  Other person† 1% 4% 3%
  Other source (not specified)/don’t know† 3% 3% 3%
  Included participants using pharmacy- available contraception (n=243)
  Female (n=111) Male (n=132) Total (n=243)
Age       
  18–19 17% 18% 18%
  20–24 83% 82% 82%
Education (highest level attended)       
  Primary or below 54% 27% 40%
  Secondary 38% 55% 47%
  Post- secondary 8% 18% 14%
Relationship status       
  Single 23% 42% 33%
  Friends with benefits 3% 8% 5%
  Dating 42% 42% 42%
  Cohabiting 3% 1% 2%
  Engaged 9% 5% 7%
  Married 20% 3% 11%
Any children       
  No 74% 92% 84%
  Yes 26% 8% 16%
Living situation       
  Lives alone 8% 23% 16%
  Lives with family (dependent) 66% 73% 70%
  Lives with child or partner 26% 4% 14%
Contraception used‡       
  Male condom 56% 86% 72%
  Female condom 4% 2% 2%
  ECP 20% 6% 12%
  Daily contraceptive pills 5% 2% 3%
  Injection 16% 5% 10%
*These included male or female condom, emergency contraception (ECP), daily contraceptive pills and injectable contraception.
†These were excluded from analysis.
‡Participants could enter one contraceptive method.
P
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Table 3 Bivariate and multivariable analysis to identify personal characteristics that may be associated with a young person 





prevalence ratio (PR) 
(95% CI) P value* Adjusted PR (95% CI) P value
All 153/243 (63%)
Age
  18–19 27/43 (63%) Ref 0.979
  20–24 126/200 (63%) 1.00 (0.78 to 1.29)
Sex
  Male 80/132 (61%) Ref 0.405
  Female 73/111 (66%) 1.09 (0.90 to 1.32)
  Education
  Primary or below 60/96 (63%) Ref 0.904
  Secondary or above 93/147 (63%) 1.01 (0.83 to 1.23)
Relationship status
  Single 46/81 (57%) 0.76 (0.61 to 0.94) 0.0013 0.75 (0.61 to 0.93) 0.0284
  Dating/‘friends with benefits’ 86/115 (75%) Ref Ref
  Married/engaged/cohabiting 21/47 (45%) 0.60 (0.43 to 0.84) 0.95 (0.67 to 1.35)
Children
  No 139/204 (68%) 1.89 (1.24 to 2.92) 0.003 1.25 (0.80 to 1.97) 0.318
  Yes 14/39 (36%) Ref Ref
Living situation
  Lives alone 30/39 (77%) 2.62 (1.51 to 4.53) 0.0024 1.96 (1.07 to 3.59) 0.0119
  Lives with family (dependent) 113/170 (66%) 2.26 (1.33 to 3.85) 1.53 (0.84 to 2.82)
  Lives with child or partner 10/34 (29%) Ref Ref
Contraception used
  Condom (M/F) 120/181 (66%) 2.36 (1.34 to 4.14) 0.0014 1.87 (1.02 to 3.43) 0.0224
  ECP 24/30 (80%) 2.84 (1.59 to 5.09) 2.27 (1.21 to 4.27)
  Pills/injection 9/32 (28%) Ref Ref
*Any variable with p values <0.2 in bivariate analysis were included in the multivariable analysis.
ECP, emergency contraception.
where health facilities were known to be busy, or evening 
and weekend hours when young people might need 
contraception.
In addition, the relative privacy offered by pharmacies 
was especially important to young clients. Participants 
perceived pharmacies, with interactions limited to a phar-
macy attendant and a client, to be far more discreet than 
similar services offered at public health facilities. Public 
health facilities had public waiting areas where young 
people may see someone they knew. In addition, services 
in the health facility might be categorised by service type 
(eg, contraceptive services separated from immunisation 
services, etc). This left young clients feeling particularly 
exposed should they need to walk up to a labelled ‘family 
planning’ window or step forward if a public announce-
ment about contraceptive services was made.
The individuals behind the counter, and how they 
interacted with young people, were additional reasons 
young people preferred to obtain contraception from 
pharmacies. Pharmacy personnel were perceived to be 
established, fellow community members. Young clients 
appreciated seeing the same familiar faces, with less of 
the personnel turnover associated with public health facil-
ities. When personnel were a similar age to young clients 
(a very strong preference of all young participants), many 
reported being able to communicate openly with phar-
macy personnel and being more comfortable interacting 
with them.
Pharmacy personnel were perceived to be non- 
judgemental compared with those working in health 
facilities. There was a perception that a trip to a facility 
would result in difficult questions and a possible refusal to 
provide the desired contraceptive. Pharmacy personnel, 
by contrast, would treat young people ‘well’. That is, they 
would provide the desired contraceptive without interro-
gation. Several participants speculated that the for- profit 
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Table 4 Reasons why pharmacies are appealing (selected excerpts from qualitative data)
Outlet appeal The physical pharmacy environment and its operation
Convenience (locations 
and hours)
“The chemist is near and whenever you want it [family planning] you can access it, anytime.” Female pharmacy purchaser: 
injection
“The good thing with chemist is that they are many of them… when you missed a certain contraceptive at a certain chemist 
you can go to the next chemist because they are several of them, not like the hospital.” Female community member (FGD)
“Yes, majority of them [young people] don’t live near health centres. Second, health centres are usually busy. And it’s not every 
day they [can be] attended to: there are specific days they have clinics… [The client] won’t be able to make it there… even if 
the treatment was free. But there is a chemist—[they] can go for similar services.” Pharmacist
Anonymity “At the chemist there are not many people. I may go to Diani dispensary [a local public health facility], and there is someone 
who knows me and I go for family planning. I saw it would be better to go the chemist because I know that will be my secret 
and the attendant.” Female pharmacy purchaser: emergency contraception
“When you go to the facility, when you go to the FP room, everyone knows that you’ve gone to get FP. For young people 
[especially] because no one will want to see me—I’m 18, I’m 16 and I’m already using family planning. I’m not supposed to 
be sexually active. The kind of population that is in those FP areas, around those FP areas it’s your mothers who are either 
breastfeeding, or they’re pregnant and have gone for ANC.” Ministry of Health official, County level
Personnel appeal The person behind the counter
Interpersonal 
relationship
“The chemist is just within the neighborhood and I know the guy he is my friend outside job so it wasn’t stressful for me in fact 
it was really fast and easy.” Male pharmacy purchaser: ECP and condoms
“The person in charge is my friend, I can go to him with my problems and he would assist me, he is not that far for me to reach 
him with my phone—he is my neighbor I could have a problem even at night and be able to reach out to him.” Male pharmacy 
purchaser: ECP
Seen as part of the 
community
“I chose it because it has been there for many years even before I was born till the time I finished school. The attendants 
are just normal. Many people get help from there so I saw it good to also go there.” Female pharmacy purchaser: ECP and 
injection
“What I had said about the hospital, when you get there you will find the person who served you before is transferred but when 
you come to the chemist you will find the person that served you before.” Female community member (FGD)
Non- judgemental “I thought at the chemist they will understand me and I would talk to them [better] than at the hospital where they will say I do 
not need to use those things or even talk to me harshly.” Male pharmacy purchaser: ECP and condoms
“At the chemist, that person wants—since it is a business—[to] just give, as compared to the hospital where when you get 
there you will find nurses who are arrogant or other doctors who will insult you.” Male community member (FGD)
Service appeal The contraception- purchasing transaction
Speed “You know at the dispensary it is a must you meet with the doctor for more explanation. And maybe there is a service you need 
to pay for, the expenses are many at the dispensary unlike the chemist where everything is fast, when you get there you get 
what you want and leave.” Youth female, has purchased ECP and condoms
“You get in a hospital, there are so many people queueing outside that are waiting to see a doctor. Here comes a young lady 
who is in a hurry. That particular person will find it more convenient to go to a chemist shop rather than going to a hospital.” 
Pharmacist
Cost “It is not easy for the government hospital. It is best, if you have money, you go to private hospitals. Now that is why you see if 
someone does not have money, or us the young people, we just go to the chemist because there is no cash to see a doctor for 
Ksh 600. At the chemist you just go direct and you are served.” Male pharmacy purchaser: ECP and condoms
“Chemists are not expensive like hospitals. In hospital you can be told it is a government hospital but you end up being asked 
to give out a lot of money. In [the] chemist the money you get asked is for [paying for] P2 [an emergency contraceptive], yah but 
in hospital you will be told to do some test because we think it is this and this.” Female pharmacy purchaser: ECP
“Free does not always mean free. Sometimes, something will be free, but by the time you get it, the process is a lot. Because 
for us, we don’t just offer family planning, we do [mandatory] counselling. The person who is going to a chemist is someone 
who has made up his or her mind. But in the public facilities, you are counselled, you are explained to, you are told the different 
methods, then you are given a chance to make an informed choice. So, I think that… is a barrier somehow.” Ministry of Health 
official, County level
aspect of pharmacies could be a reason that they were 
treated better and not refused services.
Finally, pharmacy contraception services themselves 
were appreciated for being fast and cheap. Participants 
routinely referenced the queueing for services and long 
wait times driving young people away from health facil-
ities and into pharmacies instead. Services were also 
perceived to be cheaper than both private health facility 
services as well as public health facility services. Private 
health facilities were considered out of financial reach for 
most young people—making a pharmacy a more afford-
able option. However, at public health facilities, where 
contraception- related services are meant to be free, partic-
ipants indicated that this was often not the case in prac-
tice. Expenses related to travel or ‘tests’ (eg, a pregnancy 
test) ordered by healthcare providers prior to dispensing 
contraception made real costs related to public services 
difficult to predict. Finally, as one government official 
acknowledged, even when services were free, the time 
and processes required could deter young people who 
knew what they wanted from going to facilities.
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DIsCussIOn
This mixed- method study determined pharmacies to 
be the most popular source of contraception for young 
people in a peri- urban area of Kwale County. In total, 59% 
of participants (and 63% female participants) who had 
ever had sex and self- reported use of a modern contracep-
tive at last sexual intercourse had obtained their contra-
ception from a pharmacy. This is higher than previously 
reported for Kenya as a whole.8 Multivariable analyses 
indicated that young people who were living alone relied 
more heavily on pharmacies for contraception more than 
their peers. That said, the strongest predictor of young 
people’s contraception coming from pharmacies was the 
type of contraception they used, specifically emergency 
contraception. Qualitative findings demonstrated that 
young people valued pharmacies for their convenience, 
anonymity, non- judgemental and personable staff, service 
speed, as well as predictable and affordable prices.
Together, these mixed methods indicate that pharma-
cies provide a valued source of contraception for those 
young people who may face increased scrutiny or gate-
keeping in health facilities. For young people using 
condoms or ECP, the reported convenience and speed 
of service explains the strong preference for pharmacies. 
Following unprotected sex, a young person needing ECP 
would understandably prefer to pay for it at a nearby 
pharmacy instead of travelling to a healthcare facility, 
waiting in line and negotiating with a possibly reluctant 
health worker to obtain it for free (assuming the public 
facility stocked ECP20).
This study had several limitations. In the survey, partic-
ipants were asked to specify where they or their partner 
had obtained the contraception used at last sexual inter-
course. This question is standard in studies looking to 
establish contraception prevalence. However, our not 
further ascertaining whether it was the respondent or 
their partner who picked up the contraception affected our 
ability to distinguish differences in preferred sources 
between young men who obtain contraception versus 
young women who obtain contraception. Second, to 
recruit young people who had recently purchased contra-
ception from pharmacies, we relied on assistance from 
five pharmacies, purposively selected. It is possible that 
young purchasers patronising different pharmacies might 
have had different experiences than those captured here. 
Finally, our youth participants in focus group discussions 
may have felt uncomfortable discussing contraceptive use 
in a group; we attempted to mediate this by structuring 
discussion around vignettes of ‘typical’ young people. 
This study is strengthened by its mixed- methods design 
and its use of multiple qualitative methods, and inclusion 
of both pharmacy personnel and young people to trian-
gulate research findings on a sensitive subject.
Our quantitative findings differ substantially from an 
analysis of Kenya’s DHS (KDHS) data, which found that 
nationwide, 13% of Kenyan women aged 15–24 currently 
using contraception reported obtaining it at a commer-
cial drug seller.8 There may be several reasons for this, in 
addition to the four years between the KDHS and our own 
data collection. Our study area was a peri- urban setting 
while the DHS analysis uses nationwide data. Over 70% of 
Kenya’s population is rural.21 Finally, our study’s inclusion 
of ECP and measuring contraception use at last sexual 
intercourse (rather than ‘current use’) is also a likely 
contributor. Twelve per cent of participants in this study 
used ECP at last sexual intercourse, and the KDHS did 
not specifically capture ECP use.22 The DHS’s measures 
of contraception ‘current use’ in general has been previ-
ously critiqued for not being able to capture contracep-
tive methods which may be used periodically, including 
ECP.23 Our link between ECP purchasers and pharmacies 
is in line with earlier data from urban Kenya, which indi-
cated that upwards of 96% of adult women needing ECP 
obtained it at a pharmacy.24
By contrast, our qualitative findings were largely in line 
with previous research. One systematic review featuring 
studies mostly from high- income countries (HICs) affirms 
that young people appreciate pharmacies for their conve-
nience, speed of service and ease of contraception access.9 
However, this review also reported mixed evidence (all 
from HICs) as to whether pharmacy services were consid-
ered ‘private’,9 while our study found an almost universal 
appreciation of pharmacies for their anonymity/privacy. 
This difference may be a result of different dispensing 
protocols and establishment layouts in pharmacies and 
public health facilities in HICs versus LMICs. Evidence 
from other LMICs corroborates our findings that among 
young people,25 and the general population,26 phar-
macies’ contraception services are appreciated for the 
privacy offered.
While this study focused on pharmacies, its findings also 
cover perceptions around how contraception services are 
delivered to young people in public health facilities. Phar-
macies were naturally contrasted with health facilities 
when participants explained young people’s preferences 
and were perceived to be everything that health facilities 
were not: fast, private and non- limiting. The extra ‘proce-
dures’ required to obtain contraception in health facil-
ities—which in many cases are unnecessary27 and have 
been demonstrated in other settings to limit access28 29—
were especially unwelcome for young people, who were 
uninterested in extended counselling and wary of labo-
ratory tests. As a result, pharmacy services were deemed 
more ‘predictable’ than those obtained in health facilities 
(public or private).
For Kenya, pharmacies are likely to remain a preferred 
choice of contraception as long as barrier methods and 
short- acting forms of contraception are popular with 
young people.22 Policy- makers should therefore recog-
nise their role as contraception providers, especially for 
a community’s younger members. Finding ways to link 
the myriad licensed pharmacies to focal points in public 
health facilities could strengthen a supportive ‘network’ 
of accessible and appealing contraception services 
available to young people. A similar hub- and- spoke 
approach is used in the implementation of Kenya’s 
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broader Community Health Strategy, where community 
health volunteers are embedded within the community 
and report back to a facility- based community health 
extension worker.30 Such a system, complemented by 
improved adolescent- friendliness of public health facil-
ities, would also enable easier referral of young people 
to providers who can offer them more effective forms 
of contraception. However, none of this can succeed 
without taking needed steps to improve pharmacy regu-
lation, personnel training and the overall quality of 
services.31
Our data revealed that shops were the second most 
popular source of contraception for young men. The reli-
ance on shops and lower- level drug dispensaries is seen 
elsewhere in the region: one survey in Nigeria found that 
among young people aged 15 to 24, around half sourced 
their contraception from ‘chemists/patent medicine 
shops’ (a cadre of establishment below pharmacies, which 
does not exist in Kenya).32 Unfortunately, exploring 
shops in further detail was beyond the scope of our data 
collection. Additional research is needed to understand 
how to incorporate these more informal sources into 
contraception interventions. That said, integrating them 
into the broader ‘network’ of contraception providers for 
young people will be even more challenging: lower- level 
drug dispensers are only peripherally associated with the 
health system in many settings, while shops are not asso-
ciated at all.
Finally, we must acknowledge those still left behind. Of 
participants who reported ever having sex, almost half 
of them (49%) had not used any modern contraception 
at last sexual intercourse. Aside from those who wish 
to conceive, these are young people who are not being 
reached by the current network of public and private 
health facilities, pharmacies and even neighbourhood 
shops. They are a reminder that improving the quality 
of services in these outlets is necessary but not sufficient 
to address young people’s contraceptive needs. There 
is a continued need for multi- sectoral interventions, 
including comprehensive sexuality education, to increase 
demand for contraception among youth (dispelling 
myths, addressing taboos and stigma, and increasing 
agency),33 address barriers to accessing it (including 
community norms around acceptability)3 and promote 
uptake of highly effective forms of contraception.
Young people in Coastal Kenya steadily rely on phar-
macies for contraception and often prefer them to health 
facility services. Many of the pharmacy qualities most 
appreciated by young participants are also hallmarks 
of youth- friendly health services, which should be avail-
able in any outlet a young person attends for health 
services.19 34 If a young person chooses to use modern 
contraception, their selection of an outlet will be deter-
mined by several factors, including the type of contra-
ception desired, living situation and relationship status. 
Collaboration between health facilities and retail phar-
macies at local levels can exchange operational strengths 
between these providers. Then, wherever a young person 
presents for contraceptive services, they encounter one 
part of a supportive network of quality providers.
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